Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2019 Oct 1:14:29.
doi: 10.1186/s40248-019-0193-4. eCollection 2019.

Approaching two decades of cystic fibrosis research in Qatar: a historical perspective and future directions

Samer Hammoudeh  1 , Wessam Gadelhak  1 , Atqah AbdulWahab  2 , Mona Al-Langawi  3 , Ibrahim A Janahi  2
Affiliations
Review

Approaching two decades of cystic fibrosis research in Qatar: a historical perspective and future directions

Samer Hammoudeh et al. Multidiscip Respir Med. .

Abstract

Cystic fibrosis (CF) is a genetic disease caused by a defect of CF transmembrane conductance regulator (CFTR) gene. CF affects multiple systems, predominantly with respiratory involvement. In Qatar, researchers have been exploring various aspects of the disease for almost 20 years. PubMed and Google Scholar were reviewed for articles related to CF in Qatar. The first publication appeared in the year 2000. Since then, several studies have been conducted on CF patients in Qatar considering a variety of topics. The presence of the CFTR I1234V mutation in a certain Arab tribe stands out as a distinguishing characteristic of CF patients in Qatar when compared to the larger Arab region or even worldwide. We aim here to summarize the existing CF research conducted in Qatar over the years as well as to introduce topics for future research.

Keywords: CFTR I1234V mutation; Cystic fibrosis; Cystic fibrosis transmembrane conductance regulator; Pancreatic sufficient; Qatar.

PubMed Disclaimer

Conflict of interest statement

Competing interestsThe authors declare that they have no competing interests.

References

    1. Elborn JS. Cystic fibrosis. Lancet. 2016;388(10059):2519–2531. doi: 10.1016/S0140-6736(16)00576-6. - DOI - PubMed
    1. O'Sullivan BP, Freedman SD. Cystic fibrosis. Lancet. 2009;373(9678):1891–1904. doi: 10.1016/S0140-6736(09)60327-5. - DOI - PubMed
    1. Ratjen F, Bell SC, Rowe SM, Goss CH, Quittner AL, Bush A. Cystic fibrosis. Nat Rev Dis Primers. 2015;1:15010. doi: 10.1038/nrdp.2015.10. - DOI - PMC - PubMed
    1. Filbrun Amy G., Lahiri Thomas, Ren Clement L. Handbook of Cystic Fibrosis. Cham: Springer International Publishing; 2016. Clinical Features and Complications of Cystic Fibrosis; pp. 9–41.
    1. Filbrun Amy G., Lahiri Thomas, Ren Clement L. Handbook of Cystic Fibrosis. Cham: Springer International Publishing; 2016. Introduction and Epidemiology of Cystic Fibrosis; pp. 1–4.

LinkOut - more resources